Popular GLP-1 weight-loss drugs linked to lower risks of addiction and overdose
Popular GLP-1 drugs including Ozempic, Wegovy, Mounjaro, and Zepbound have already transformed the treatment of type 2 diabetes and obesity. Now, new research suggests these medications may also help prevent and treat addiction across a broad range of substances. Researchers at Washington University School of Medicine in St. Louis found that GLP-1 medications were associated…
